Genom Analysis’ Post

A rapidly evolving genomic revolution is poised to shape the future of healthcare, but its full clinical potential can be realized only with the development of a multidisciplinary healthcare workforce Genomic tests (such as those based on whole-exome or whole-genome sequencing) generate an enormous amount of highly complex data, which requires professionals with specialized bioinformatic skills and computational expertise, and the know-how to operate within clinically accredited frameworks. Also, physicians themselves will need to be better prepared to work confidently with genetic information #genomics #genomicmedicine #healthcare https://lnkd.in/gfsSkrQp

Exploring the transformative potential of automating genomic data reanalysis, this insightful study published in the European Journal of Human Genetics delves into the future of clinical genomics for undiagnosed rare diseases. Through interviews with Australian clinical and lab staff, it navigates the shift from manual to automated processes, addressing challenges and strategizing for effective implementation. This pivotal research paves the way for enhanced clinical care and patient outcomes through streamlined, automated genomic reanalysis. #Genomics #ClinicalGenomics #Automation #RareDiseases #PatientCare #Innovation.

"Genomics is a disruptive technology that will transform health care across the entire course of a person’s life, from pre-conception to end-of-life care. " In this insightful essay, Kathryn North, Director at the Murdoch Children's Research Institute shed light on the potential of genomic medicine, and how it is poised to revolutionize healthcare and provide personalized care through analyzing genetic information. Read the essay here: https://lnkd.in/gfpsq4V5 #Medicine #Genomics #FutureofHealthcare #Technology #Research

What is the better technology to use – exome (ES) or genome (GS) sequencing? With few published head-to-head comparisons, a recent meta-analysis (https://hubs.ly/Q02cJfY90) of 161 studies from 31 countries/regions aimed to draw the comparison in a diverse population of patients with rare disease. They found that ES and GS offer similar diagnostic rates of 30-35%. GS provided an increased clinical utility over ES without an impact on VUS rates. Hear more about how they applied their findings to their own decision making on GenePods (https://hubs.ly/Q02cJ8Tq0). Remember, knowledge is power, and staying informed about the latest advancements in genetic testing can lead to better patient outcomes. Let's continue to push the boundaries of precision medicine together! #ExomeSequencing #GenomeSequencing #RareDiseases #ClinicalUtility #GeneChat #AmbryTopTenPublications

At #Davos 2024, the spotlight on Genomic & Genetic Medicine unveiled transformative insights, from redefining health systems to influencing care delivery, the intersection of genetics and healthcare promises a paradigm shift in patient-centric approaches. @ftlive

Curating clinically relevant interpretations of genetic variants can be challenging. Velsera's Clinical Genomics Workspace (CGW) is here to assist you! Our software equips your team with the latest medical data to ensure reliable interpretations and the best therapeutic options for the patient. CGW saves you time when analyzing genomic interpretations by: 🔸Structuring interpretations systematically for convenient review and modification. 🔸Remembering your decisions about past biomarker from previous cases to enable faster sign-out time. Interested in learning more? Watch the recording: https://lnkd.in/gBe6kBkD #NGS #PrecisionMedicine #EraOfVelsera #Genomics

💡 The Promise of Genomic Medicine: Genome sequencing is opening the door to targeted treatments, early disease detection, and a new era of personalized medicine. The possibilities are endless, and the future is now. #PersonalizedMedicine #HealthcareInnovation

If you're looking for a tertiary analysis software, please sign up for the Emedgene webinar. #illumina #webinar #raredisease #genomeinsight #Emedgene

What are the considerations when choosing a new tertiary analysis software? Laboratories need solutions that are innovative, integrated, customisable and able to meet their needs. Join us on November 9th to learn how @Illumina Emedgene software can help you unlock genomic insights and confidently scale your tertiary analysis workflows for rare disease genomics and other germline research applications. Register today! #raredisease #germline #tertiaryanalysis #genomics #AI #automation

In support of #rarediseaseday, Stephen Kingsmore willing posed with me in my zebra stripes at Rady Children's Institute for Genomic Medicine! Every single day Dr. Kingsmore and all my other colleagues work to make ultra-rapid whole genome sequencing testing available for every patient who might benefit. For us, it's our mission to try to take some of the burden off the moms and dads of those little kiddos who tenaciously strive to find answers and get help for their kids. I can't imagine what they go through. #raredisease #rarediseaseday #wholegenomesequencing #genetictesting #geneticdisease